{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "ACTINOGEN MEDICAL LTD.", "longName": "Actinogen Medical Limited", "messageBoardId": "finmb_36482293", "market": "dr_market", "marketState": "REGULAR", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 1806249984, "bookValue": 0.009, "fiftyDayAverage": 0.0297, "fiftyDayAverageChange": -0.0067, "fiftyDayAverageChangePercent": -0.22558922, "twoHundredDayAverage": 0.04478, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -6.1224465, "regularMarketPrice": 0.023, "regularMarketChange": -0.0014999993, "regularMarketTime": 1683871418, "regularMarketDayHigh": 0.023, "regularMarketDayRange": "0.023 - 0.023", "regularMarketDayLow": 0.023, "regularMarketVolume": 30000, "regularMarketPreviousClose": 0.0245, "bid": 0.023, "ask": 0.0485, "bidSize": 46667, "askSize": 37500, "fullExchangeName": "Frankfurt", "financialCurrency": "AUD", "regularMarketOpen": 0.023, "averageDailyVolume3Month": 1694, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.008, "fiftyTwoWeekLowChangePercent": 0.53333336, "fiftyTwoWeekRange": "0.015 - 0.099", "fiftyTwoWeekHighChange": -0.076, "fiftyTwoWeekHighChangePercent": -0.7676768, "fiftyTwoWeekLow": 0.015, "fiftyTwoWeekHigh": 0.099, "twoHundredDayAverageChange": -0.021780001, "twoHundredDayAverageChangePercent": -0.48637787, "marketCap": 65553912, "priceToBook": 2.5555556, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "firstTradeDateMilliseconds": 1192773600000, "priceHint": 4, "symbol": "3AC.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "109 Pitt Street", "address2": "Suite 901 Level 9", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 8964 7401", "fax": "61 2 8964 7588", "website": "https://www.actinogen.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11\u00df-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.", "age": 62, "title": "MD, CEO & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 358742, "fmt": "358.74k", "longFmt": "358,742"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeff  Carter BFinAdmin, MAppFin", "age": 64, "title": "Chief Financial Officer", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 76481, "fmt": "76.48k", "longFmt": "76,481"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tamara  Miller", "title": "Sr. VP of Product Devel.", "fiscalYear": 2022, "totalPay": {"raw": 275659, "fmt": "275.66k", "longFmt": "275,659"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Paul  Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.", "title": "Head of Clinical Pharmacology & Lead Physician and Depression", "fiscalYear": 2022, "totalPay": {"raw": 111211, "fmt": "111.21k", "longFmt": "111,211"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Roberts", "title": "Head of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Therese  Russell", "title": "Head of People & Infrastructure", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christian  Toouli", "title": "Head of Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Dana C. Hilt M.D.", "age": 69, "title": "Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD", "age": 59, "title": "Company Sec.", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}